Stay updated on CTX110 in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:55:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T18:08:49.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:16:02.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse and the older Revision: v3.4.1 were removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:33:53.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a government funding notice banner and a site version update (v3.4.1); these changes do not affect the study details, eligibility criteria, or trial data on the page.
    Difference
    0.3%
    Check dated 2026-02-04T05:27:37.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added glossary display and several study metadata fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and removed the estimated indicators and older revision labeling.
    Difference
    0.2%
    Check dated 2026-01-28T03:58:12.000Z thumbnail image

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.